Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 403
Selected: 0
| NCT ID | Title | ||
|---|---|---|---|
| NCT03176082 | Mailed Reminders Plus Fecal Immunochemical Testing | ||
| NCT02045186 | Monitoring of Oral Human Papillomavirus Infection (HPV) in HPV-positive Oropharyngeal Squamous Cell Carcinoma (OPSCC) | ||
| NCT03529422 | Durvalumab With Radiotherapy for Adjuvant Treatment of Intermediate Risk SCCHN | ||
| NCT02700022 | A Phase I Study of Alisertib + R-EPOCH for Treatment of Myc-Positive Aggressive B-cell Lymphomas | ||
| NCT01138345 | Biomarkers in Blood Samples From Older Breast Cancer Survivors | ||
| NCT03620019 | Denosumab + PD-1 in Subjects With Stage III/ IV Melanoma | ||
| NCT01845519 | Step by Step: A Tailored Walking Intervention for Breast Cancer Survivors | ||
| NCT04342871 | An Evaluation of the Families Addressing Cancer Together (FACT) Intervention | ||
| NCT06860880 | Combating Cancer-Related Fatigue: A Personalized Supportive Care Program | ||
| NCT03977233 | Tumor Subtypes in Subjects on FOLFIRINOX With Non-Metastatic Pancreatic Cancer | ||
| NCT01759355 | Hybrid PET/MR in the Therapy of Cervical Cancer | ||
| NCT00246753 | Lapatinib in Treating Patients With Prostate Cancer That Did Not Respond to Hormone Therapy | ||
| NCT04083495 | CD30 CAR for Relapsed/Refractory CD30+ T Cell Lymphoma | ||
| NCT06276946 | Sparing Parotid Ducts Via MRI Sialography for Reduced Patient Reported Xerostomia | ||
| NCT05311670 | Pre-Implementation Study of Improving Thoracic Surgical Care Using Electronic Patient-Reported Outcomes (ePROS) | ||
| NCT02609503 | Pembrolizumab + Radiation for Locally Adv SCC of the Head and Neck (SCCHN) Not Eligible Cisplatin | ||
| NCT03488862 | Pilot Evaluation of a Microfluidic Assay to Detect Minimal Residual Disease and Predict Relapse in AML Patients | ||
| NCT05828654 | Intervention to Address Psychosocial Needs Among Socially Disadvantaged Older Adults With Cancer | ||
| NCT03160183 | Investigating Chemotherapy Treatments, Response and Subsets of HIV-associated Kaposi Sarcoma in Malawi | ||
| NCT05377749 | The Families Addressing Cancer Together Intervention for Parents With Cancer | ||
| NCT03594162 | Compassionate Use of CAR T Cells Targeting the CD19 Antigen and Containing the Inducible Caspase 9 Safety Switch | ||
| NCT07276880 | Preoperative Chemotherapy, Pembrolizumab and Low or High Dose RADiation in an Expansion Cohort of Node(+), Triple Negative Breast Cancer | ||
| NCT01605344 | Crossover Evaluation of Effect of Atorvastatin on PK of Irinotecan in CRC Patients Receiving FOLFIRI | ||
| NCT04990934 | Transitioning Care: Perspectives of Older Women With Early Breast Cancer on Current Telemedicine Modalities | ||
| NCT04033419 | Memantine for Prevention of Cognitive Decline in Patients With Breast Cancer | ||
| NCT06817226 | BREAST Choice Decision Tool R21 - AIM2 | ||
| NCT03016377 | Administration of Autologous CAR-T CD19 Antigen With Inducible Safety Switch in Patients With Relapsed/Refractory ALL | ||
| NCT03196037 | Feasibility of an 8-week Tai Chi Chuan Intervention for Breast Cancer Survivors | ||
| NCT06896162 | PROGRESS: Precision Oncology Using Genomic Reflexive Evaluations for Study Selection and Survival | ||
| NCT00280787 | Induction Chemotherapy Using Paclitaxel, Carboplatin, CPT-11 With Pegfilgrastim | ||
| NCT01725048 | Pilot Study to Evaluate Individualized Choice of Antidepressants in Patients With Cancer | ||
| NCT02798224 | A Patient Portal Tool, E-assist, for Supporting CRC Screening | ||
| NCT01323062 | Bavituximab Plus Carbo and Pemetrexed in Chemo-Naive Stage IV Non-Squamous Non-Small Cell Lung Cancer (NSCLC) Subjects | ||
| NCT02585973 | Dose-escalating AZD1775 + Concurrent Radiation + Cisplatin for Intermediate/High Risk HNSCC | ||
| NCT04142554 | Parsaclisib in Newly Diagnosed Stage I-IIIC Triple Negative or HER2+ Breast Cancer | ||
| NCT01875666 | Defining the HER2 Positive (+) Breast Cancer Kinome Response to Trastuzumab, Pertuzumab, Combination Trastuzumab +Pertuzumab, or Combination Trastuzumab + Lapatinib | ||
| NCT00448357 | Allogeneic Hematopoietic Cell Transplantation for Patients With Busulfex-based Regimen | ||
| NCT02328300 | FLT PET/MR for Evaluation of Pseudoprogression in Patients With Brain Lesions | ||
| NCT01688336 | FOLFIRINOX for Unresectable Locally Advanced and Borderline Resectable Pancreatic Cancer | ||
| NCT00006108 | Capecitabine, Paclitaxel, and Trastuzumab in Treating Patients With Metastatic Breast Cancer | ||
| NCT02030353 | The Use of Smart Scales for Weight Gain Prevention in African American Breast Cancer Survivors | ||
| NCT01560663 | Predictors of Response to Neoadjuvant Docetaxel-Carboplatin Chemotherapy for Patients With Stage II and III Triple Negative Breast Cancer | ||
| NCT03785782 | ARFI, VisR and DDAI Ultrasound for Improving Discrimination of Malignant and Unresponsive Breast Cancer | ||
| NCT04292847 | LCCC1931:Post-treatment Intervention in Women With Breast Cancer (70y/o+) | ||
| NCT06075316 | Improving Thoracic Surgical Care Using Electronic Patient-Reported Outcomes (ePROS) | ||
| NCT05911308 | Abequolixron (RGX-104) and Durvalumab in Lung Cancer | ||
| NCT05742386 | Impact of Standing Orders Optimization | ||
| NCT04073966 | MRI Biomarkers for Radiation-Induced Neurocognitive Decline Following SRS of Newly Diagnosed Brain Mets | ||
| NCT02781025 | Culture of Circulating Tumor Cells Isolated From Cancer Patients With Metastatic Disease | ||
| NCT05743426 | Disease Outcomes and Toxicities in Patients With Gastrointestinal and Sarcomatous Malignancies |
